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The high chloride content of 0.9% saline leads to adverse
pathophysiological effects in both animals and healthy
human volunteers, changes not seen after balanced
crystalloids. Small randomized trials confirm that the
hyperchloremic acidosis induced by saline also occurs in
patients, but no clinical outcome benefit was demonstrable
when compared with balanced crystalloids, perhaps due to a
type II error. A strong signal is emerging from recent large
propensity-matched and cohort studies for the adverse
effects that 0.9% saline has on the clinical outcome in
surgical and critically ill patients when compared with
balanced crystalloids. Major complications are the increased
incidence of acute kidney injury and the need for renal
replacement therapy, and that pathological hyperchloremia
may increase postoperative mortality. However, there are no
large-scale randomized trials comparing 0.9% saline with
balanced crystalloids. Some balanced crystalloids are
hypo-osmolar and may not be suitable for neurosurgical
patients because of their propensity to cause brain edema.
Saline may be the solution of choice used for the
resuscitation of patients with alkalosis and hypochloremia.
Nevertheless, there is evidence to suggest that balanced
crystalloids cause less detriment to renal function than 0.9%
saline, with perhaps better clinical outcome. Hence, we argue
that chloride-rich crystalloids such as 0.9% saline should be
replaced with balanced crystalloids as the mainstay of fluid
resuscitation to prevent ‘pre-renal’ acute kidney injury.
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Any rational approach to fluid and electrolyte therapy and
volume resuscitation must take into account the evolved
mammalian responses to stress, starvation, injury, or infec-
tion. These responses preserve the blood supply to essential
organs, allowing time for the individual to recover, and
activate the host defense and repair pathways. In simple
terms, the major evolved responses relevant to fluid manage-
ment are as follows:
 Maintenance of perfusion of the heart, brain, and lungs at
the expense of the cutaneous, splanchnic, and renal
circulations.
 Fluid shifts from the intracellular and interstitial compart-
ments to replenish the depleted vascular compartment.
 An increase in systemic vascular permeability allowing
proteins such as immunoglobulins and albumin, with their
attendant fluid, to move from the vascular space into the
interstitial compartment.
 Intense sodium and water retention by the kidneys to
augment the reduced circulating blood volume.
In addition to the evolutionary response to conserve salt
and water, the patient’s ability to excrete administered salt
and water is also limited by renal compromise and reduced
ability to concentrate urine. As a consequence, it requires 2–4
times the normal volume of urine to excrete the sodium and
chloride load administered, which competes with excretion
of nitrogen resultant from catabolic stress during critical
illness, resulting in interstitial edema.
Although Evans1 commented on the dangers of the
reckless way in which salt solutions were prescribed as early
as 1911, the clinical effects of salt and water excess have
largely been ignored till relatively recently, with continued
inappropriate and excessive use of chloride-rich crystalloid
infusions, such as 0.9% saline, both within the settings of
resuscitation and maintenance. The development of balanced
crystalloids highlights the need to reappraise the continued
use of 0.9% saline, especially considering the detrimental
effects the latter has on renal function. In this debate we
argue against the use of this unphysiological crystalloid, more
appropriately termed ‘abnormal saline’,2,3 and appraise both
historical and recent data that support the argument.
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RATIONALE FOR FLUID RESUSCITATION—THE KIDNEY
From the renal perspective, the aim of fluid resuscitation of
the hypovolemic patient is to improve renal blood flow,
increase glomerular filtration rate (GFR), and reduce the
incidence of acute kidney injury (Figure 1). However, the
ability of fluid therapy to achieve this aim is dependent on a
number of other factors including the type of fluid used and
the effects of acute illness, chronic disease, and drugs that
may alter determinants of fluid responsiveness. The latter
include systemic vascular resistance, myocardial compliance
and contractility, regional blood flow distribution, venous
capacitance, and capillary permeability.4 Teleologically, the
kidney is better adapted to conservation of salt and water
than to excreting an excess of either.5 In addition, factors
such as hypotension, pain, and injury activate the sympathe-
tic nervous system and the renin–angiotensin–aldosterone
system. Subsequent release of the antidiuretic hormone
overrides normal homeostatic mechanisms and leads to
further sodium and water retention. Even in the absence of
renal impairment, the relationship between fluid input and
natriuresis is weak, and the administration of intravenous
fluid may lead to salt and water accumulation rather
than a diuresis,3,6,7 effects that are exaggerated with
0.9% saline when compared with balanced crystalloids,
which bear a closer resemblance to the constituents of
plasma (Table 1).
HOW DID 0.9% SALINE COME INTO BEING?
Although traditionally believed to have originated during the
European cholera pandemic in 1831, none of the intravenous
saline solutions described between 1832 and 1895 bore any
resemblance to 0.9% saline.8 The first reference to a solution
bearing similarity to 0.9% saline appeared in an 1896 article
by Lazarus-Barlow, where Hamburger, a Dutch physiological
chemist, was cited as the main authority for suggesting that a
concentration of 0.92% saline was ‘normal’ for mammalian
blood.9 Hamburger performed experiments on the effects of
varying the concentration of salt solutions on erythrocyte
fragility.10 He found that ‘for every salt a concentration could
be obtained in which the least resistant blood corpuscles lost
their coloring matter’ and speculated that ‘the salt solutions
used caused a swelling which a number of the blood cor-
puscles could not withstand without losing their coloring
matter’. It was accepted that the freezing point of human
serum was  0.52 1C. On the basis of his experiments on
erythrocyte fragility and freezing points of mammalian
serum, Hamburger concluded that ‘the blood of the
majority of warm-blooded animals, including man, was
isotonic with a NaCl solution of 0.9 per cent., and not of 0.6
per cent., as was generally thought...and which had always
been called the physiological NaCl solution’.11 The scientific
evidence supporting the use of 0.9% saline in clinical practice
seems to have originated solely on these in vitro studies, and,
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Figure 1 | Rationale for fluid resuscitation to prevent acute
kidney injury.
Table 1 | Composition of 0.9% saline and some commonly used balanced crystalloids
Human plasma
0.9% Sodium
chloride Hartmann’s
Ringer’s
lactate
Ringer’s
acetate
Plasma-Lyte
148
Plasma-Lyte A
pH 7.4
Sterofundin/
Ringerfundin
Osmolarity (mOsm/l) 275–295 308 278 273 276 295 295 309
pH 7.35–7.45 4.5–7.0 5.0–7.0 6.0–7.5 6.0–8.0 4.0–8.0 7.4 5.1–5.9
Sodium (mmol/l) 135–145 154 131 130 130 140 140 145
Chloride (mmol/l) 94–111 154 111 109 112 98 98 127
Potassium (mmol/l) 3.5–5.3 0 5 4 5 5 5 4
Calcium (mmol/l) 2.2–2.6 0 2 1.4 1 0 0 2.5
Magnesium (mmol/l) 0.8–1.0 0 0 0 1 1.5 1.5 1
Bicarbonate (mmol/l) 24–32
Acetate (mmol/l) 1 0 0 0 27 27 27 24
Lactate (mmol/l) 1–2 0 29 28 0 0 0 0
Gluconate (mmol/l) 0 0 0 0 0 23 23 0
Maleate (mmol/l) 0 0 0 0 0 5
Na:Cl ratio 1.21:1 to 1.54:1 1:1 1.18:1 1.19:1 1.16:1 1.43:1 1.43:1 1.14:1
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given the evidence presented below, it is unlikely that 0.9%
saline would had progressed beyond a phase I clinical trial
had it been developed in recent times.
ANIMAL STUDIES
As early as 1948, a fall in arterial pH from 7.55 to 7.21 was
demonstrated in dogs after an infusion of 1.5 liter of 0.9%
saline (300ml/h), but not after that of a ‘balanced salt
solution’ containing NaHCO3.
12 In a canine model of
Escherichia coli endotoxin–induced septic shock, mean saline
requirement to maintain mean arterial pressure480mmHg
was 1833ml over 3 h.13 The pH decreased from 7.32 to 7.11
(Po0.01) and serum chloride increased (from 128 to
137mmol/l, P¼ 0.016), without changes in pCO2, serum
lactate, and sodium. In a study on anesthetized dogs that had
one kidney auto-transplanted to the neck, thereby dener-
vating it, infusion of chloride-containing solutions resulted
in hyperchloremia that produced progressive concentration-
dependent renal vasoconstriction and a decrease in GFR
independent of renal innervation.14
Three swine studies have compared the effects of resuscita-
tion using 0.9% saline and Ringer’s lactate (RL) after 30min
of uncontrolled hemorrhage.15–17 Compared with RL,
resuscitation with 0.9% saline required significantly greater
volumes (256±145ml/kg saline vs. 126±67ml/kg RL,
P¼ 0.04) to attain pre-injury mean arterial pressure.17
Hyperchloremic acidosis and dilutional coagulopathy were
noted with saline.17 Hypercoagulability and low blood loss
were noted with RL.15 Extravascular lung water index
increased with both fluids, but this occurred earlier and to
a greater degree after saline.16 Another study examined the
effects of resuscitation using four crystalloids (0.9% saline,
RL, Plasmalyte-A (Pl-A), and Plasmalyte-R (Pl-R)) in a
model of rapid hemorrhage in 116 unanesthetized pigs.18
Aortic blood (54ml/kg) was removed over a period of
15min, and the replaced volume was 14% in 5min with
saline, 100% in 20min with saline, and 300% in 30min with
saline, RL, Pl-A, or Pl-R. In animals that had 300%
replacement of shed blood in 30min, RL provided the best
survival rate of 67% (e.g., 50% for saline, 40% for Pl-R, and
30% for Pl-A). The investigators hypothesized that the lower
survival rates in animals that were resuscitated with Pl-R and
Pl-A may have resulted from the acetate constituent, which
may have had differential regional vasodilatory and vaso-
constrictive effects in these animals.18 After removal of 40%
of total blood volume in three equal aliquots at 30-min
intervals, pigs received saline (mean volume infused:
2865ml), RL (2774ml), or Plasma-Lyte (2681ml), in a
blinded manner over 15min, at a volume that was three times
that of the blood removed.19 All three solutions attenuated
hemorrhage-induced low cardiac output and anuria equally,
but saline induced negative base excess and a significant
hyperchloremia.19
A rat study compared the effects of resuscitation with saline
and RL following moderate (mean 36% estimated blood
volume) and massive hemorrhage (mean 218% estimated
blood volume).20 The animals with moderate hemorrhage
were bled to a MAP of 60mm Hg for 2 h, then resuscitated
with the appropriate crystalloid for 1 h. In these animals,
resuscitation with saline and RL was equivalent. The final
hematocrit, pH, and base excess were not different, and all
animals survived. In the massive hemorrhage group, animals
resuscitated with salineþ blood were significantly more
acidotic than animals resuscitated with equal volumes of
RLþ blood (pH 7.14 vs. 7.39, Po0.01) and had significantly
worse survival (50 vs. 100%, Po0.05).20 Furthermore, some
salineþ blood-resuscitated animals developed profound
acidosis associated with cardiorespiratory arrest in some
cases and early death in others. Hyperchloremic acidosis also
resulted in increased concentrations of circulating inflam-
matory mediators in an experimental model of severe sepsis
in rats, with a dose-dependent increase in circulating
interleukin-6, tumor necrosis factor-a, and interleukin-10
concentrations with increasing acidosis.21
In a sheep model of septic shock (intravenous adminis-
tration of live E. coli), resuscitation with saline (20ml/kg over
15min), versus observation, resulted in transient reversal of
the hemodynamic effects of septic shock but had no effect on
renal blood flow.22 Interestingly, infusion of 25ml/kg saline
over 20min in normovolemic conscious and anesthetized
sheep altered fluid kinetics in the anesthetized group by
reducing urinary excretion and resulting in interstitial fluid
accumulation.23 A porcine model24 of elevated intra-
abdominal pressure demonstrated a progressive decrease in
renal venous and arterial blood flow with increasing intra-
abdominal pressure. Development of renal interstitial edema
has been hypothesized to contribute, at least in part, to
development of a ‘renal compartment-syndrome’–type effect
due to kidney parenchymal swelling within the tough
unyielding capsule, contributing to onset of anuria/oliguria
in acute tubular necrosis. In a study on the effects of renal
decapsulation in 12 rhesus monkeys subjected to cross-
clamping of the suprarenal aorta for periods of 15–55min
followed by declamping, split ureteral function tests demon-
strated that renal decapsulation resulted in better preserva-
tion (threefold higher) of creatinine, urea, and free water
clearance.25 Pathological examination revealed that kidneys
with an intact capsule were either smaller than their decap-
sulated partners or obviously atrophic.25 Edema-related
subcapsular pressure elevation was examined in a murine
model of renal ischemia reperfusion.26 After 24 h of elevated
subcapsular pressures, significant reductions were noted in
tubular excretion rates and renal perfusion, coupled with
severe tissue damage on histological examination. Surgical
capsulotomy effectively prevented these functional and
structural alterations.26
EFFECTS OF 0.9% SALINE ON ACID–BASE BALANCE
Large volume infusions (50ml/kg over 1 h) of 0.9% saline in
healthy volunteers have been shown to be associated with a
persistent acidosis and delayed micturition, and to produce
abdominal discomfort and pain, nausea, drowsiness, and
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decreased mental capacity to perform complex tasks, but
these changes were not noted after infusion of identical
volumes of Hartmann’s solution.27 Slow excretion of saline
after a 2-liter intravenous load, with only 29% having been
excreted after 195min, has also been reported.28 A further
comparison of the effects of 2-liter infusions of 0.9% saline
and Hartmann’s solution over 1 h in healthy volunteers has
confirmed the sluggish urinary response after saline infusion,
which occurs at the expense of the production of a significant
and sustained hyperchloremia.3 At 6 h, 56% of the infused
saline was retained, in contrast to only 30% of the
Hartmann’s solution. Time to first micturition was quicker,
and urine volumes and sodium excretion were greater after
infusion with Hartmann’s solution than after saline. Similar
changes were also noted when 2-liter infusions of saline were
compared with those of Plasma-Lyte 148.6 In addition,
although calculated blood volume expansion was similar
after the two infusions, interstitial fluid accumulation was
significantly greater after saline than after Plasma-Lyte.6
The hyperchloremic acidosis caused by infusion of
moderate-to-large quantities of 0.9% saline can last for
several hours after the end of the infusion even in healthy
volunteers3,6,7,27,29 and may reflect the lower [Naþ ]:[Cl ]
ratio in saline (1:1) than in balanced crystalloids (1.18–1.43:1) or
in plasma (1.38:1).30 Two theories have been proposed to
explain this phenomenon: dilutional acidosis31,32 and the
Stewart hypothesis.33
It has been proposed that infusion of large volumes of
saline causes a decrease in serum bicarbonate concentration
due to a dilutional effect, resulting in acidosis.31,32 The effects
of randomly allocated 2-h infusions of almost 70ml/kg
(i.e., up to 5 liters) of 0.9% saline or Hartmann’s solution
were studied in patients undergoing elective gynecological
operations.34 There was a significant decrease in pH (7.41–7.28),
serum bicarbonate concentration (23.5–18.4mmol/l), and
anion gap (16.2–11.2mmol/l), accompanied by an increase in
serum chloride concentration (104–115mmol/l) during the
first 2 h of saline infusion. Although pH, bicarbonate, and
chloride concentrations did not change significantly after
Hartmann’s solution, the anion gap decreased (15.2–12.1mmol/l).
The volume of fluid replacement in this study34 may be
considered excessive, but it confirmed that hyperchloremic
acidosis accompanied saline infusions in patients. In a study
of 30 patients undergoing major surgery, randomly allocated
to receive either 0.9% saline or Plasma-Lyte 148 at 15ml/kg/h,
those receiving saline had significantly increased chloride
concentrations (D[Cl ] þ 6.9 vs. þ 0.6mmol/l, Po0.01),
decreased bicarbonate concentrations (D[HCO3
 ]  4.0 vs.
 0.7mmol/l, Po0.01), and increased base deficit (D base
excess  5.0 vs.  1.2mmol/l, Po0.01) compared with those
receiving Plasma-Lyte 148.35 There were no significant
changes in plasma sodium, potassium, or lactate concen-
trations in either group.35
However, in healthy volunteers, the fall in serum bicar-
bonate concentration after saline infusions is in the range of
1–2mmol/l (refs. 3, 6, 7, 27, 29) and this, on its own, does not
explain development of acidosis on the basis of the
Henderson-Hesselbach equation. Crystalloid infusions are
also associated with a decrease in serum albumin concen-
tration, even in healthy subjects.3,6,7,27,29,34 The negatively
charged albumin molecule accounts for about 75% of the
anion gap36 and acute dilutional hypoalbuminemia can
effectively reduce the upper limit of the normal range for
the anion gap.32 In critically ill patients, the anion gap has
been shown to reduce by 2.5mmol/l for every 10 g/l decrease
in serum albumin concentration.37 However, once again,
development of acidosis cannot be explained entirely as
albumin concentrations fall even after the infusion of
balanced crystalloids or 5% dextrose.3,6,7,27,29,34
Hence, the mechanism of acidosis after infusions of 0.9%
saline may be better explained by the Stewart hypothesis.33
This describes a mathematical approach to acid–base balance
based on the apparent strong ion difference (SIDa,
[Naþ ]þ [Kþ ]—[Cl ]) being the major determinant of
Hþ ion concentration. A decrease in SIDa is associated with
metabolic acidosis and an increase with metabolic alkalosis.
Hyperchloremia consequent on saline infusions decreases
the SIDa, and is the process that results in a metabolic
acidosis.32,34,38,39 Canine experiments on resuscitation from
septic shock have shown that 0.9% saline accounted for 42%
of the acidosis observed, whereas lactate was responsible for
only 10%.13
EFFECTS OF SALINE EXCESS AND HYPERCHLOREMIA ON THE
KIDNEY
Healthy human volunteer studies have shown that retention
of fluid in the interstitial space is greater after infusions of
0.9% saline, than after those of balanced crystalloids or 5%
dextrose, and that this fluid retention is associated with
reduced urine volume. Drummer et al.40 studied the urinary
excretion of water and electrolytes and the changes in
hormones controlling body fluid homeostasis during the 48 h
following an infusion of 2 liters of 0.9% saline over 25min
and after a 48 h control experiment. Urine volume and
electrolyte excretion rates were significantly increased in the 2
days following saline infusion, with the largest increase being
observed between 3 and 22 h post infusion. The authors
suggested that the antidiuretic hormone, natriuretic peptide,
and catecholamines were unlikely to be of major importance
for the renal response to this hypervolemic stimulus. The
renin–angiotensin–aldosterone system was suppressed during
the 2 days post infusion, which correlated with the effects of
saline load on sodium excretion. However, the closest relation
with Na excretion was observed for the kidney-derived
member of the atrial natriuretic peptide family, urodilatin,
which was considerably increased during the long-term
period up to 22 h post infusion.40 Thus, these data show
that humans require approximately 2 days to restore normal
sodium and water balance after an acute saline infusion and
that urodilatin and the renin–angiotensin–aldosterone system
may participate in the long-term renal response to such
infusions. A more recent study has also suggested that the
Kidney International (2014) 86, 1096–1105 1099
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excretion of salt and water after saline infusions is dependent
on a slow and sustained suppression of the renin–angiotensin–
aldosterone system rather than differential responses to the
antidiuretic hormone or natriuretic peptides.7
The greater diuresis of water after infusion with Hartmann’s
solution compared with 0.9% saline may be partly explained
by its lower osmolality and the reduced antidiuretic hormone
secretion that this may have engendered.3,27 However, these
differences between balanced crystalloids are maintained even
when isotonic crystalloids such as Plasma-Lyte 148 are used.6
Veech30 had emphasized previously that, when large amounts
of saline are infused, the kidney is slow to excrete the excess
chloride load. He also suggested that, as the permeability of
the chloride ion across cell membranes was voltage dependent,
the intracellular chloride content was a direct function of
membrane potential. In animal studies, sustained renal
vasoconstriction was specifically related to hyperchloremia,
which was potentiated by previous salt depletion and related
to the tubular reabsorption of chloride,14 which appeared to
be initiated by an intrarenal mechanism independent of the
nervous system and was accompanied by a decrease in GFR.
Although changes in renal blood flow and GFR were
independent of changes in the fractional reabsorption of
sodium, they correlated closely with changes in the fractional
reabsorption of chloride, suggesting that renal vascular
resistance was related to the delivery of chloride, but not
sodium, to the loop of Henle.14 Chloride-induced vasocon-
striction appeared to be specific for the renal vessels and the
regulation of renal blood flow and GFR by chloride could
override the effects of hyperosmolality on the renal
circulation.14 Other animal experiments have shown that
Kþ -induced reduction in renal vessel diameter was both
dependent on and responsive to increasing extracellular
chloride.41,42 Moreover, at pathologically elevated concentra-
tions, chloride led to severe renal vasoconstriction.41 It has
also been shown in an experimental rat model of salt-
sensitive hypertension that, although loading with sodium
chloride produced hypertension, that with sodium bicar-
bonate did not.43 Studies on young adult men have shown
that plasma renin activity was suppressed 30 and 60min after
infusion of sodium chloride, but not after infusion of sodium
bicarbonate, suggesting that both the renin and blood
pressure responses to sodium chloride are dependent on
chloride.43 A recent healthy volunteer study using magnetic
resonance imaging has shown, for the first time in humans,
that acute infusions of 2 liters of 0.9% saline can cause a
reduction in renal artery flow velocity and renal cortical
tissue perfusion when compared with a balanced crystalloid,
and that this may be associated with the hyperchloremia
caused by saline.6 The role of the macula densa in providing
tubulo-glomerular feedback to afferent vessels and the
signaling pathway leading to changes in GFR has been
elucidated recently.44,45 Increased renal tubular chloride
concentration can result in the entry of chloride into cells
of the macula densa causing depolarization of the basolateral
membrane via chloride channels.46 This can lead to
adenosine release from the macula densa, which through its
effects on the A1 receptor causes afferent arteriolar vasocon-
striction47 and provides the signal for increased afferent
arteriolar resistance and reduced GFR, leading to reduced
urine volume and sodium excretion (Figure 2).44,45
Saline infusions have been shown to cause a greater
increase in interstitial fluid volume (and, hence, edema) than
balanced crystalloids and this may lead to a relatively greater
increase in renal volume.6 Even small increases in the volume
of an organ enclosed by a relatively non-expansible capsule
may lead to intracapsular hypertension, which may further
compromise tissue perfusion, reduce microvascular blood
flow, and impair organ function.25 Increase in renal intracap-
sular pressure may decrease the pressure gradient across the
renal arterioles and, in keeping with Poiseuille’s law, may
have an additional impact on decreasing flow velocity.6
Improvement in renal function and increased urine output
have been demonstrated in kidneys subjected to capsulotomy
following massive preoperative volume replacement with
blood and crystalloids in hypovolemic monkeys.25
Furthermore, just as the increased interstitial fluid over-
load caused by large volumes of saline infusions can result
in peripheral edema, it may also cause splanchnic edema,
intestinal stretch increased abdominal pressure, ascites,48 and
even the abdominal compartment syndrome,49 which can
further compromise renal and gastrointestinal function.50–54
CLINICAL STUDIES IN SURGICAL OR CRITICALLY ILL
PATIENTS
Although human studies3,6,7,27,29,30,34,55–58 have confirmed
that 0.9% saline infusions lead to a hyperchloremic metabolic
acidosis, which causes detriment to renal function, until
recently there was no firm evidence that the use of saline led
to adverse patient outcomes. In a relatively recent review the
authors commented, ‘ythere appear to be some side-effects
associated with saline use, but to date these have not
translated into clinically important outcomes, though this
may be through lack of data’.59
A review of the literature, however, fails to reveal a single
clinical study showing 0.9% saline to be superior to balanced
crystalloids. Nevertheless, the absence of studies demonstrat-
ing better clinical outcomes with balanced crystalloids until
relatively recently has led to the continued use of 0.9% saline
in most areas of practice. Studies in the perioperative34,35 and
resuscitation60 settings have shown that 0.9% saline causes
a hyperchloremic acidosis when compared with balanced
crystalloids. These studies were on relatively small numbers
of patients and, although they did not demonstrate a
difference in clinical outcome between the groups, they
suggested that the temporary hyperchloremic acidosis
produced by the use of 0.9% saline could be given a false
pathological significance and that it could also exacerbate an
acidosis resulting from a definite pathological state. Happily,
over the past few years a few studies have suggested that 0.9%
saline leads to more adverse events than balanced crystalloids,
and, hence, worse patient outcomes.
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There are two randomized controlled double-blind trials
(n¼ 66 (ref. 61) and n¼ 51 (ref. 62)) comparing 0.9% saline
with RL in the perioperative period, with both showing that
the use of 0.9% saline resulted in more adverse events
compared with RL. In patients undergoing abdominal aortic
aneurysm repair, those receiving saline needed significantly
greater volumes of packed red blood cells (780 vs. 560ml),
platelets (392 vs. 223ml), and bicarbonate therapy (30 vs.
4ml) than those receiving RL.61 Although median blood loss
was 600ml greater in the saline group, this difference was not
significant. Hyperchloremic acidosis was demonstrable in the
saline group, but this did not result in an apparent difference
in outcome other than the need for larger amounts of
bicarbonate to correct base deficit and the use of greater
volumes of blood products.61 A study on patients undergoing
renal transplantation had to be stopped prematurely because,
compared with none in those receiving RL, 19% of patients
in the saline group had to be treated for hyperkalemia and
31% for metabolic acidosis. Being a double-blind study, the
data monitoring committee thought that the hyperkalemia
occurred in the RL group.62 Although there was no statisti-
cally significant difference in postoperative renal function
when the two groups were compared, patients who received
saline tended to have a lower 4 h postoperative urine output
(1.6 vs. 2.1 l) and 24 h creatinine clearance (84 vs. 94ml/min)
than those receiving RL.62 Another recent double-blind study
randomized adult trauma patients requiring blood transfu-
sion, intubation, or operation within 60min of arrival to
receive either 0.9% saline or Plasma-Lyte A for resuscitation
during the first 24 h after injury.60 Of the 65 patients
randomized, 46 were evaluable and the authors showed
that the improvement in base excess from 0 to 24 h
was significantly greater with Plasma-Lyte A than with 0.9%
saline (mean difference (95% confidence interval (CI)): 3.1
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Figure 2 | Schematic diagram of the sequential effects of hyperchloremia on the kidney. Numbers indicate the sequence of events.
A1-receptor, adenosine1-receptor.
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(0.5 to to 5.6) mmol/l). At 24 h, arterial pH was greater (0.05
(0.01 to 0.09)) and serum chloride concentration was lower
( 7 ( 10 to  3) mmol/l) with Plasma-Lyte A than with
0.9% saline. However, there was no significant difference
between groups when volumes of fluid administered, 24 h
urine output, resource utilization, and clinical outcomes were
compared. As these studies60–62 were performed on relatively
small groups of patients, it is quite possible that the lack of
difference in clinical outcome measures, such as postopera-
tive complications or length of hospital stay, between the two
groups may represent a type II error.
In a double-blind study aimed at quantifying changes in
acid–base balance, potassium and lactate concentrations after
administration of different crystalloids during kidney trans-
plantation, 90 patients were randomized to three groups to
receive 0.9% saline, RL, or Plasma-Lyte at 20–30ml/kg/h.63
There was a significant decrease in pH and base excess, and
a significant increase in serum chloride concentration in
patients receiving saline but not the balanced crystalloids
during surgery. Lactate concentrations increased significantly
in patients who received RL, but not after Plasma-Lyte.
Clinical outcomes were not reported, but there were no
significant differences between groups in postoperative renal
function tests or the need for hemodialysis.63 Other clinical
studies have also shown similar changes in pH, acid-base
status, and serum chloride concentrations without differences
in clinical outcome when 0.9% saline was compared with
balanced crystalloids in the perioperative setting.64–67
Recent large observational studies68–71 have suggested that
the high chloride content of 0.9% saline may cause adverse
events, especially when renal outcomes are considered.
Evaluation of outcomes in a propensity-matched study of
2788 adults undergoing major open abdominal surgery who
received only 0.9% saline and in 926 patients who received
only a balanced crystalloid on the day of surgery, recorded
in a validated and quality-assured database, showed that
unadjusted in-hospital mortality (5.6 vs. 2.9%) and the
percentage of patients developing complications (33.7 vs.
23%) were significantly greater (Po0.01) in those receiving
0.9% saline than in those receiving the balanced crystalloid.69
Although mortality in the saline group remained higher after
correction for confounding variables, the difference ceased to
be significant. Patients in the 0.9% saline group received an
average of 316ml more fluid (Po0.001), had a greater need
for blood transfusion (odds ratio (95% CI): 11.5 (10.3 to
12.7) vs. 1.8 (1.2 to 2.9)%, Po0.001) and more infectious
complications (Po0.001), and were 4.8 times more likely
to require dialysis (Po0.001) than those in the balanced
crystalloid group. Overall complications were fewer in the
balanced crystalloid group (odds ratio (95% CI): 0.79 (0.66
to 0.97)).
Further support for chloride-restrictive fluid strategies
in critically ill patients is provided by a recent open-label
prospective sequential study, in which patients consecutively
admitted to intensive care (30% after elective surgery)
received either traditional chloride-rich (0.9% sodium
chloride, 4% succinylated gelatin solution, or 4% albumin
solution, n¼ 760) or chloride-restricted regimens (Hartmann’s
solution, Plasma-Lyte 148, or chloride-poor 20% albumin,
n¼ 773).70 After adjusting for confounding variables, patients
in the chloride-restricted group had a decreased incidence of
acute kidney injury (odds ratio (95% CI): 0.52 (0.37 to 0.75),
Po0.001) and the use of renal replacement therapy (odds
ratio (95% CI) 0.52 (0.33 to 0.81), P¼ 0.004). However, there
were no differences in hospital mortality, or in the length of
hospital or intensive care unit stay.70 In an earlier study using
a similar design, the same group of authors71 showed that,
after introduction of a low-chloride regimen (n¼ 816), the
incidence of severe metabolic acidosis decreased from 9.1 to
6.0% (Po0.001) and that of severe acidemia from 6.0 to
4.9% (Po0.001) when compared with a high-chloride
regimen (n¼ 828). However, the intervention also led to a
significantly greater incidence of severe metabolic alkalosis
and alkalemia with an increase from 25.4 to 32.8% and 10.5
to 14.7%, respectively (Po0.001). The time-weighted mean
chloride concentration decreased from 104.9 to 102.5mmol/l
(Po0.001), whereas the standard base excess increased from
0.5 to 1.8mmol/l (Po0.001), and mean pH from 7.40 to 7.42
(Po0.001). Clinical outcomes were, however, not reported in
this study.
A study on 22,851 surgical patients with normal preopera-
tive serum chloride concentration and renal function
demonstrated a 22% incidence of acute postoperative hyper-
chloremia (serum chloride 4110mmol/l).68 Of the 4955
patients with hyperchloremia after surgery, 4266 (85%)
patients were propensity matched with an equal number of
patients who had normochloremia postoperatively. Patients
with hyperchloremia were at increased risk of 30-day post-
operative mortality (3.0 vs. 1.9%; odds ratio (95% CI): 1.58
(1.25 to 1.98)) and had a longer median hospital stay (7.0
days (interquartile range 4.1–12.3) vs. 6.3 days (interquartile
range 4.0–11.3), Po0.01) than those with normal postopera-
tive serum chloride concentrations.68 Patients with postop-
erative hyperchloremia were also more likely to have
postoperative renal dysfunction as defined by a 425%
decrease in GFR (12.9 vs. 9.2%, Po0.01). Contrary to what
was previously believed,32,59 this study68 has shown that
hyperchloremic metabolic acidosis is not a benign, self-
limiting, metabolic disturbance.
BALANCED CRYSTALLOIDS AND SERUM POTASSIUM
CONCENTRATION
As balanced crystalloids contain potassium, they were
traditionally considered to be contraindicated in the presence
of hyperkalemia or situations with a potential for hyperka-
lemia, such as diabetic ketoacidosis or rhabdomyolysis.
However, the maximum concentration of potassium in
balanced crystalloids is 5mmol/l, which gets rapidly diluted
in extracellular fluid after infusion. This is unlikely to cause
an appreciable increase in serum potassium concentrations
and four recent small-scale studies have reinforced this
view.72–75
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A single-blind study randomized patients with rhabdo-
myolysis (creatinine kinase 41000 IU/l) secondary to
doxylamine intoxication to receive infusions of either 0.9%
saline (n¼ 15) or RL (n¼ 13) at rates of 400ml/h.72 Median
urinary (4.25 vs. 5.5) and serum pH (7.44 vs. 7.36) were
significantly higher in the RL group than in patients who
received saline. There were no significant differences in serum
potassium concentrations, but patients in the saline group
had higher serum sodium and chloride concentrations. Median
time to creatinine kinase normalization (o200 IU/l) was 96 h
in the RL group compared with 120 h in the saline group, and
it was found that patients in the RL group did not develop
metabolic acidosis and needed little supplemental sodium
bicarbonate.72
A small retrospective study on patients with diabetic keto-
acidosis examined differences between those who received
exclusively 0.9% saline (n¼ 14) or Plasma-Lyte 148 (n¼ 9)
for the initial 12 h of resuscitation.73 Median serum
bicarbonate concentrations were higher (Po0.05) in the
Plasma-Lyte group at 4–6 h (8.4 vs. 1.7mmol/l) and 6–12 h
(12.8 vs. 6.2mmol/l) and these were associated with a faster
resolution of metabolic acidosis. Interestingly, at 6–12 h from
baseline, serum potassium concentration was significantly
lower in the Plasma-Lyte group (3.9 (3.4–4.0) mmol/l) than
the saline group (4.3 (4.1–4.8)mmol/l, Po0.05). The
Plasma-Lyte group also had higher mean arterial blood
pressure at 2–4 h, higher cumulative urine output, and lower
serum chloride concentrations at 24 h. There were no
differences in glycemic control or duration of intensive care
unit stay between the two groups.73 A double-blind study
that randomized patients with diabetic ketoacidosis to receive
either 0.9% saline (n¼ 29) or RL (n¼ 28) similarly failed to
demonstrate differences in serum potassium concentration
between the two groups at 10 h from baseline.75
Similar findings were noted in studies that examined the
effects of different infusions in treating dehydration76,77 and
acute pancreatitis.78 A double-blind study randomized 90
consecutive moderate-to-severely dehydrated adults to receive
0.9% saline, RL, or Plasma-Lyte at 20ml/kg/h for 2 h.77 At the
end of the study infusions, serum bicarbonate concentrations
decreased leading to a tendency to lower pH values in the
saline group. No significant changes were noted in potassium,
sodium, or chloride concentrations.77 An observational study
of 40 dehydrated patients with choleriform diarrhea
examined the effects of treatment with 50ml/kg/h of either
RL or 0.9% saline.76 RL led to quicker resolution of acidosis,
whereas the hyperosmolar and hypernatremic states were
corrected with both solutions. Although the saline group had
lower serum potassium concentrations at baseline, there were
no significant differences in potassium concentrations at
2 and 14 h following infusion of the study fluids.76 Finally, a
randomized study examined goal-directed (n¼ 19) versus
standard (n¼ 21) fluid resuscitation in 40 patients with acute
pancreatitis.78 Patients, randomized to either 0.9% saline or
RL, received an initial bolus of 20ml/kg over 30min
for resuscitation followed by a 3ml/kg/h infusion for
maintenance. There were no differences in total fluid volumes
used (B4.5 liters in 24 h). Infusion of RL was associated with
significant reductions in systemic inflammatory response
after 24 h (84 vs. 0% reduction in saline group, P¼ 0.035)
and reduced CRP concentrations (51.5 vs. 104mg/dl,
P¼ 0.02). Although the aforementioned study78 did not
report peri-infusion serum potassium concentrations, there
were no reported adverse events of hyperkalemia.
CONCLUSIONS
This comprehensive review of literature has shown that 0.9%
saline is neither ‘normal’ nor ‘physiological’ and that its high
chloride content leads to many pathophysiological changes,
especially with regard to renal function, in both animals and
healthy human volunteers. These changes are not seen after
infusions with balanced crystalloids. Small randomized
clinical trials have shown that the hyperchloremic acidosis
induced by saline is also seen in patients, but this did not
translate into being a detriment to clinical outcomes when
compared with balanced crystalloids, perhaps because of a
type II error. Other small studies have shown that it may
be safe to use potassium-containing balanced crystalloids
in situations where hyperkalemia may be expected. However,
it must be remembered that in this situation the evidence is
not strong enough and larger studies are required before
general recommendations for the use of balanced crystalloids
in the presence of hyperkalemia can be made.
A strong signal is emerging from recent large propensity-
matched and cohort studies for the adverse effects that large
volumes of 0.9% saline have on clinical outcome in surgical
and in critically ill patients when compared with balanced
crystalloids. The major adverse events are the increased
incidence of acute kidney injury and the need for renal
replacement therapy caused by 0.9% saline and the resultant
hyperchloremia. There is also an increase in other side effects
and resource utilization (Figure 3), and pathological hyper-
chloremia has been associated with increased postoperative
mortality. However, as there are no large-scale randomized
trials yet comparing 0.9% saline with balanced crystalloids,
the current evidence cannot be regarded as Grade A.
It must also be remembered that some balanced crystal-
loids such as Hartmann’s solution and RL are hypo-osmolar
and may not be suitable for neurosurgical patients and those
with head injuries because of their propensity to cause brain
edema. This effect may not be seen with isotonic balanced
crystalloids such as Plasma-Lyte 148 and Sterofundin, but as
yet there is no evidence to support this. Balanced crystalloids
are not suitable for the resuscitation of patients with alkalosis
and hypochloremia (e.g., profound vomiting) and in this
situation 0.9% saline may be the solution of choice. The
newer balanced crystalloids contain anions, such as gluco-
nate, acetate, and malate, and the physiological effects and
potential adverse effects of these substances have not yet been
fully elucidated, and it must be remembered that the ‘perfect’
crystalloid does not exist.
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Nevertheless, on the basis of current literature there is
adequate evidence to suggest that balanced crystalloids are more
physiological than 0.9% saline and cause less detriment to renal
function, with perhaps better clinical outcome. Hence, we
submit that we have presented a coherent argument to recom-
mend that chloride-rich crystalloids such as 0.9% saline should
be replaced with balanced crystalloids as the mainstays of fluid
resuscitation to prevent ‘pre-renal’ acute kidney injury.
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